Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04188041
Other study ID # 1370981-4
Secondary ID U54GM115677
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 2, 2019
Est. completion date July 31, 2022

Study information

Verified date March 2022
Source Kent Hospital, Rhode Island
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study explores primary care team members' knowledge, attitudinal, and skill gaps related to LTBI testing and treatment. The gaps identified will inform the design of a survey and telementoring educational program (TB infection ECHO course). The EMR data query will further explore the reach of the ECHO model. The hypothesis for this study is that the TB infection ECHO course will be feasible, will have a significant impact on primary care provider participants' learning and performance related to LTBI testing and treatment in their primary care practices, and will increase the number of LTBI tests and treatment prescribed in primary care.


Description:

This pilot study will use a mixed-methods design called an exploratory sequential translational research design. In this type of study design, the initial qualitative phase informs the design of an intervention (in this case a TB infection ECHO) and an instrument (in this case structured surveys) to study the intervention. The third phase implements the designed intervention and/or instrument to collect data and quantitatively assess the outcomes of interest (in this case feasibility and impact). The final aspect of the third phase explores an EMR data query to assess the reach of the intervention (providers' testing and treatment in the real world). In Aim 1, 30 primary care team members from our Brown Family Medicine, Care New England, and federally qualified health center networks will be purposively sampled to undergo key informant interviews regarding LTBI testing and treatment knowledge, attitudinal, and skill gaps. Questions will be asked to ascertain gaps throughout the entire latent TB infection care cascade. The results from Aim 1 will be used to design the survey instrument and the curriculum for an innovative, telementoring program (TB infection ECHO). In Aim 2, at least 20 additional primary care team members will be recruited to participate in a virtual six-month TB infection ECHO course. Participants will complete quantitative surveys before and after the course as well as post-session surveys following each session. Survey questions will assess feasibility measures related to process, resources, and management and impact measures related to learning and performance. Paired data from pre- and post-course surveys will be analyzed accordingly depending on the distribution of results. In Aim 3, data will be extracted from two ECHO participants' clinic sites before, during, and after ECHO implementation. Data will include information about LTBI testing and treatment to understand the reach and impact of the intervention of providers' testing and treatment behavior. This study will lead to an ECHO research framework that can be used for future ECHO courses that address other diseases in Rhode Island.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 30
Est. completion date July 31, 2022
Est. primary completion date March 24, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - > 18 years of age - Primary care team members in Rhode Island including doctors, nurses, nurse practitioners, physician assistants, or other healthcare providers who are involved in primary care. Exclusion Criteria: - < 18 years of age - Primary care team members who do not primarily work in Rhode Island

Study Design


Related Conditions & MeSH terms


Intervention

Other:
TB Infection ECHO
A six-month virtual telementoring course regarding TB infection testing and treatment that incorporates didactics, case presentation, and discussion

Locations

Country Name City State
United States Brown Family Medicine Department Pawtucket Rhode Island

Sponsors (2)

Lead Sponsor Collaborator
Kent Hospital, Rhode Island National Institute of General Medical Sciences (NIGMS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility: Participant Attendance Proportion of registered participants attending each ECHO session Six-month ECHO course
Primary Feasibility: Participant Retention Proportion of registered participants attending one of the last two ECHO sessions Six-month ECHO course
Primary Impact: Procedural knowledge Change in participants' confidence in knowing TB infection testing and treatment procedures based on a likert scale rating (1=not at all confident and 5=extremely confident) included in the pre- and post- structured surveys administered before and after the ECHO intervention. Six-month ECHO course
Primary Impact: Self- reported LTBI screening Change in participants' self-reported estimates of patients screened for TB infection. Participants will estimate their screening on a 5 item scale with 0 patients being the lowest and >50 patients being the highest. Change in scores will be calculated between the pre- and post- structured survey responses administered before and after the ECHO intervention. Six-month ECHO course
Primary Impact: Self- reported LTBI treatment Change in participants' self-reported estimates of patients treated for TB infection. Participants will estimate their TB treatment on a 5 item scale with 0 patients being the lowest and >50 patients being the highest. Change in scores will be calculated between the pre- and post- structured survey responses administered before and after the ECHO intervention. Six-month ECHO course
Primary Reach: LTBI testing Proportion(# of TB tests/# of visits) of patients tested for LTBI in a health center population before, during and after ECHO implementation to assess providers' behavior change. This data will be obtained from an electronic medical record data query Three-months prior, ECHO course, three- months post
Primary Reach: LTBI treatment Patient level LTBI treatment before, during and after ECHO implementation to assess providers' behavior change. Proportion(# of TB treatment initiated/# of patients diagnosed with LTBI) of patients treated for LTBI in a health center population before, during and after ECHO implementation to assess providers' behavior change. This data will be obtained from an electronic medical record data query. Three-months prior, ECHO course, three- months post
Secondary Feasibility: Case Submission Proportion of cases submitted on time during the ECHO course Six-month ECHO course
Secondary Feasibility: ECHO session timing Proportion of participants' who agree that session timing was convenient. This will be collected monthly from post-session surveys via a likert scale (1=strongly disagree and 5=strongly agree) Six-month ECHO course
Secondary Feasibility: Connectivity Proportion of participants' who agree that connectivity was adequate during the ECHO session. This will be collected monthly from post-session surveys via a likert scale (1=strongly disagree and 5=strongly agree) Six-month ECHO course
Secondary Feasibility: Videoconferencing Equipment Proportion of participants' who agree that videoconferencing equipment was adequate during the ECHO session. This will be collected monthly from post-session surveys via a likert scale (1=strongly disagree and 5=strongly agree) Six-month ECHO course
Secondary Feasibility: Content expert facilitation Proportion of participants' who agree that the quality of content expert facilitation was adequate during the ECHO session. This will be collected monthly from post-session surveys via a likert scale (1=strongly disagree and 5=strongly agree) Six-month ECHO course
Secondary Feasibility: Communication with ECHO hub Proportion of participants' who agree that the communication with the ECHO hub team was adequate during the ECHO session. This will be collected monthly from post-session surveys via a likert scale (1=strongly disagree and 5=strongly agree) Six-month ECHO course
See also
  Status Clinical Trial Phase
Recruiting NCT05073926 - Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis
Not yet recruiting NCT04428294 - Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation Phase 4
Completed NCT02276755 - Vitamin D Supplementation in TB Prevention Phase 3
Withdrawn NCT03498534 - Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis Phase 4
Active, not recruiting NCT03988933 - 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB. Phase 2
Recruiting NCT06022146 - TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts Phase 3
Recruiting NCT03730181 - Tuberculosis Clinical Trials Consortium Study 35 Phase 1/Phase 2
Completed NCT01967134 - Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis Phase 1
Completed NCT00257907 - Immune Response to Mycobacterium Tuberculosis Infection
Recruiting NCT05756582 - Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students
Active, not recruiting NCT04557176 - TB Screening Improves Preventive Therapy Uptake N/A
Completed NCT02119130 - Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa N/A
Not yet recruiting NCT06281834 - Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention Phase 1
Not yet recruiting NCT02512484 - Improving the Detection of Active Tuberculosis in Accident and Emergency Departments N/A
Completed NCT00763295 - Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV? N/A
Completed NCT01850043 - The Epidemiology of TST Change in Korea N/A
Completed NCT02073669 - Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults N/A
Completed NCT02090374 - Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen N/A
Completed NCT02880982 - Trial of Vitamin D Supplementation in Cape Town Primary Schoolchildren Phase 3
Withdrawn NCT03783728 - Video Based Directly Observed Therapy for Latent TB